QQQ   314.87 (+0.69%)
AAPL   161.72 (+0.59%)
MSFT   282.09 (+0.56%)
META   207.55 (+1.07%)
GOOGL   100.64 (-0.74%)
AMZN   101.90 (+1.65%)
TSLA   195.86 (+1.02%)
NVDA   272.54 (+1.00%)
NIO   10.71 (+8.95%)
BABA   104.21 (+4.29%)
AMD   98.12 (+2.11%)
T   19.01 (+0.05%)
F   12.27 (+1.83%)
MU   63.07 (-0.74%)
CGC   1.79 (-1.38%)
GE   94.07 (+0.01%)
DIS   97.88 (+1.04%)
AMC   4.95 (-1.00%)
PFE   40.29 (+0.10%)
PYPL   74.06 (-0.16%)
NFLX   338.21 (+1.86%)
QQQ   314.87 (+0.69%)
AAPL   161.72 (+0.59%)
MSFT   282.09 (+0.56%)
META   207.55 (+1.07%)
GOOGL   100.64 (-0.74%)
AMZN   101.90 (+1.65%)
TSLA   195.86 (+1.02%)
NVDA   272.54 (+1.00%)
NIO   10.71 (+8.95%)
BABA   104.21 (+4.29%)
AMD   98.12 (+2.11%)
T   19.01 (+0.05%)
F   12.27 (+1.83%)
MU   63.07 (-0.74%)
CGC   1.79 (-1.38%)
GE   94.07 (+0.01%)
DIS   97.88 (+1.04%)
AMC   4.95 (-1.00%)
PFE   40.29 (+0.10%)
PYPL   74.06 (-0.16%)
NFLX   338.21 (+1.86%)
QQQ   314.87 (+0.69%)
AAPL   161.72 (+0.59%)
MSFT   282.09 (+0.56%)
META   207.55 (+1.07%)
GOOGL   100.64 (-0.74%)
AMZN   101.90 (+1.65%)
TSLA   195.86 (+1.02%)
NVDA   272.54 (+1.00%)
NIO   10.71 (+8.95%)
BABA   104.21 (+4.29%)
AMD   98.12 (+2.11%)
T   19.01 (+0.05%)
F   12.27 (+1.83%)
MU   63.07 (-0.74%)
CGC   1.79 (-1.38%)
GE   94.07 (+0.01%)
DIS   97.88 (+1.04%)
AMC   4.95 (-1.00%)
PFE   40.29 (+0.10%)
PYPL   74.06 (-0.16%)
NFLX   338.21 (+1.86%)
QQQ   314.87 (+0.69%)
AAPL   161.72 (+0.59%)
MSFT   282.09 (+0.56%)
META   207.55 (+1.07%)
GOOGL   100.64 (-0.74%)
AMZN   101.90 (+1.65%)
TSLA   195.86 (+1.02%)
NVDA   272.54 (+1.00%)
NIO   10.71 (+8.95%)
BABA   104.21 (+4.29%)
AMD   98.12 (+2.11%)
T   19.01 (+0.05%)
F   12.27 (+1.83%)
MU   63.07 (-0.74%)
CGC   1.79 (-1.38%)
GE   94.07 (+0.01%)
DIS   97.88 (+1.04%)
AMC   4.95 (-1.00%)
PFE   40.29 (+0.10%)
PYPL   74.06 (-0.16%)
NFLX   338.21 (+1.86%)
OTCMKTS:ORPEF

Orpea - ORPEF Stock Forecast, Price & News

$2.41
0.00 (0.00%)
(As of 03/29/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.41
▼
$2.41
50-Day Range
$2.17
▼
$9.46
52-Week Range
$2.17
▼
$43.00
Volume
N/A
Average Volume
1,880 shs
Market Capitalization
N/A
P/E Ratio
1.32
Dividend Yield
24.92%
Price Target
N/A

Orpea MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.48mentions of Orpea in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.35 out of 5 stars

See Top Rated MarketRank™ Stocks Here

ORPEF stock logo

About Orpea (OTCMKTS:ORPEF) Stock

Orpea SA engages in the operation of geriatric healthcare facilities. It operates through the following geographical segments: France Benelux UK Ireland, Central Europe, Eastern Europe, Iberian Peninsula/Latin America, and Others. Its services include nursing homes, psychiatric care clinics, home care, and post-acute and rehabilitation clinics. The company was founded by Jean-Claude Marian in 1989 and is headquartered in Puteaux, France.

Receive ORPEF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orpea and its competitors with MarketBeat's FREE daily newsletter.

ORPEF Stock News Headlines

March 28, 2023 | finance.yahoo.com
ORPEA Completes a New Step of Its Financial Restructuring Process With the Opening of an Accelerated Safeguard Procedure
March 28, 2023 | msn.com
Orpea shares defy looming debt swap price
March 30, 2023 | Weiss Ratings (Ad)
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
March 27, 2023 | bloomberg.com
Orpea Shares Still Trade 10 Times Above Post-Restructuring Value
March 27, 2023 | marketwatch.com
Orpea Shares Slump After Court Opens Safeguard Procedure
March 27, 2023 | marketwatch.com
French Court Opens Safeguard Procedure for Orpea
March 24, 2023 | bloomberg.com
Billionaire Peugeot Dynasty Takes Hit From Scandal-Ridden Orpea
March 20, 2023 | finance.yahoo.com
ORPEA: Adhesion to the Restructuring Plan Proposed by the Company of a Majority of Its Unsecured Financial Creditors
March 30, 2023 | Weiss Ratings (Ad)
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
February 23, 2023 | msn.com
French care homes group Orpea's debt restructuring talks extended
February 19, 2023 | finance.yahoo.com
ORPEA Group: 2022 Activity: Revenue Of €4,681 Million1, Up +8.9%
February 18, 2023 | finance.yahoo.com
ORPEA: Signature of the Lock-up Agreement Relating to the Financial Restructuring Plan
February 13, 2023 | uk.investing.com
Orpea shares jump on Q4 revenue and cash boost
February 13, 2023 | marketwatch.com
Orpea Shares Rise Following Update on Revenue, Capital Hikes
February 13, 2023 | msn.com
UPDATE 1-Orpea: planned capital hikes would reflect theoretical share price below 0.20 euros
February 9, 2023 | technews.tmcnet.com
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Orpea SA (ORPEF) Investigation
February 6, 2023 | msn.com
Orpea shares continue to skid after restructuring deal announced
February 1, 2023 | reuters.com
France's scandal-hit Orpea reaches restructuring agreement
January 31, 2023 | msn.com
France's public lender CDC to take over Orpea - Liberation
January 31, 2023 | msn.com
Nursing care homes company Orpea resumes talks with creditors, asks to suspend shares and bonds
January 30, 2023 | marketwatch.com
Orpea to Halt Listing as Restructuring Talks Resume
January 20, 2023 | msn.com
France's investment arm CDC says offer to restructure Orpea 'still on table'
December 22, 2022 | marketwatch.com
Orpea Shares Fall After 2022 Impairment Views Double
December 21, 2022 | money.usnews.com
Orpea Says It Filed Criminal Complaint Against Former CEO
December 17, 2022 | ca.finance.yahoo.com
Orpea SA (ORP.PA)
November 25, 2022 | bloomberg.com
More Orpea Creditors Team Up to Stake Claims in Restructuring
November 23, 2022 | bloomberg.com
German Debt Lenders Could Shun Foreign Issuers After Orpea Saga
See More Headlines
Receive ORPEF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orpea and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Medical Care Facilities
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ORPEF
CUSIP
N/A
CIK
N/A
Web
www.orpea-corp.com
Phone
(314) 775-7807
Fax
N/A
Employees
39,957
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
1.32
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Laurent Guillot
    Chief Executive Officer & Non-Independent Director
  • Laurent Lemaire
    Executive Vice President-Finance & Purchasing
  • Laure Frères
    Executive Vice President-Quality, Medical & CSR
  • Pierre Krolak-Salmon
    Executive Vice President & Medical Director
  • Geert Uytterschaut
    Chief Executive Officer-Northern Europe Region

Key Competitors

View All Competitors













ORPEF Stock - Frequently Asked Questions

Should I buy or sell Orpea stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orpea in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" ORPEF shares.
View ORPEF analyst ratings or view top-rated stocks.

How have ORPEF shares performed in 2023?

Orpea's stock was trading at $5.85 at the beginning of 2023. Since then, ORPEF stock has decreased by 58.8% and is now trading at $2.4075.
View the best growth stocks for 2023 here.

Are investors shorting Orpea?

Orpea saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 83,700 shares, an increase of 316.4% from the January 31st total of 20,100 shares. Based on an average trading volume of 2,700 shares, the days-to-cover ratio is presently 31.0 days.
View Orpea's Short Interest.

Is Orpea a good dividend stock?

Orpea (OTCMKTS:ORPEF) pays an annual dividend of $0.60 per share and currently has a dividend yield of 1.46%. The dividend payout ratio is 32.78%. This payout ratio is at a healthy, sustainable level, below 75%.

What is Orpea's stock symbol?

Orpea trades on the OTCMKTS under the ticker symbol "ORPEF."

How do I buy shares of Orpea?

Shares of ORPEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orpea's stock price today?

One share of ORPEF stock can currently be purchased for approximately $2.41.

How many employees does Orpea have?

The company employs 39,957 workers across the globe.

How can I contact Orpea?

Orpea's mailing address is 12 rue Jean Jaurès, Paris, Ile-de-France 92800. The official website for the company is www.orpea-corp.com. The company can be reached via phone at (314) 775-7807.

This page (OTCMKTS:ORPEF) was last updated on 3/30/2023 by MarketBeat.com Staff